China to provide technology for cervical cancer screening

A hospital of federal capital has joined hands with Landing Med, medical technology company, based in Wuhan China, to make use of the artificial intelligence (AI) in advancing cervical cancer screening.

According to a statement issued by Dr Akbar Niazi Teaching Hospital (ANTH), the collaboration, driven by the pursuit of cutting-edge research and development, aims to redefine the landscape of cervical cancer screening for Pakistani women.

“Under the ambit of the China-Pakistan AI Cervical Cancer Screening Program, Landing Med has provided multiple state-of-the-art, self-developed cervical cancer screening devices, complemented by a large number of sets of consumable items.

“This infusion of advanced technology is poised to bring about a transformative shift in the early detection of cervical cancer, utilising the power of artificial intelligence,” it stated.

Yasir Khan Niazi, CEO of ANTH, described the initiative as a pivotal step towards seamless integration of technology into the fabric of cancer screening for Pakistani women.

“The AI-powered devices, equipped with unparalleled speed, efficiency and accuracy, promise to detect traces of cancer cells within minutes. Beyond swiftness, the devices leverage comprehensive algorithm models and decades of diagnostic data, ensuring early diagnosis that is speedy, precise and reliable,” he said.

Dr. Sun Xiaorong, Founder and President of Landing Med, emphasised the crucial role of efficient testing methods, particularly in countries with substantial female populations like Pakistan.